Patent · US Active

Bipartite inhibitors of bacterial RNA polymerase

US9415112B2 · kind B2 · utility

2Cited by
4References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 20, 2012
Grant dateAug 16, 2016
Priority date
Expiry dateJun 20, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides bipartite inhibitors of bacterial RNA polymerase having the general structural formula (I): X-α-Y (I) wherein X is an moiety that binds to the rifamycin binding site of a bacterial RNA polymerase, Y is a moiety that binds to the GE23077 binding site of a bacterial RNA polymerase, and is a linker. The invention also provides compositions comprising such compounds, methods of making such compounds, and methods of using said compounds. The invention has applications in control of bacterial gene expression, control of bacterial growth, antibacterial chemistry, and antibacterial therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.